| NAME |
METHYLPHENIDATE HCL (EQV-APTENSIO XR) 15MG CAP,SA |
| VA GENERIC NAME |
METHYLPHENIDATE |
| DOSAGE FORM |
CAP,SA |
| FDA MED GUIDE |
Methylphenidate_SA_(Aptensio XR)_(2019).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Schedule II Non-Narcotics |
| STRENGTH |
15 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG |
| NATIONAL FORMULARY NAME |
METHYLPHENIDATE CAP,SA |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2020-06-10 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
METHYLPHENID(EQV-APTENSIO XR)15MG SA CAP |
| VA PRODUCT IDENTIFIER |
M1239 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
CAP |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4039449 |
| EFFECTIVE DATE/TIME |
-
- 2020-06-10 00:00:00
- STATUS: ACTIVE
|
